NCT02998957

Brief Summary

Introduction: Chronic obstructive pulmonary disease (COPD) presents with a gradual reduction and little bitterness reversible airflow causing shortness of breath, chronic cough and sputum abnormal. Patients with COPD often suffer exacerbations of their symptoms, particularly dyspnea, causing hospital admissions. Recent studies have shown that acupuncture stimulation transcutánea (AcuTENS) Dingchuan point (EX-B1) could help reduce dyspnea in patients with COPD. Objective: The aim of this study was to evaluate the possible utility of adding to the usual treatment stimulation AcuTENS in COPD patients admitted with severe dyspnea. Methodology: Patients who agree to participate will be randomly divided into two groups. The intervention group will receive a daily treatment, during the period of hospitalization, 45 minutes stimulation at acupuncture point AcuTENS Dingchuan (EX-B1), while the control group performed the same procedure with a device TENS simulated. The extent of dyspnea in both groups as well as the number of days of hospitalization and the number of drugs consumed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 21, 2016

Completed
1.3 years until next milestone

Study Start

First participant enrolled

April 1, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

October 2, 2018

Status Verified

September 1, 2018

Enrollment Period

1.2 years

First QC Date

November 30, 2016

Last Update Submit

September 30, 2018

Conditions

Keywords

AcupunctureTENSPhysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Dyspnoea

    Change from baseline using the modified Borg scale

    At baseline, day 1, day 2, day 3 day 4 and day 5 of the study.

Secondary Outcomes (10)

  • Hospitalization days

    Up to 1 months after discharge

  • Quantity of drug administered

    Up to 1 months after discharge

  • Peak expiratory flow

    At baseline, day 1, day 2, day 3 day 4 and day 5 of the study.

  • PaO2

    At baseline, day 1, day 2, day 3 day 4 and day 5 of the study. (only if there is a medical indication for it)

  • Mortality

    Up to 3 months after discharge

  • +5 more secondary outcomes

Study Arms (2)

AcuTENS

EXPERIMENTAL

Stimulation using a portable TENS electrostimulation device at Dingchuan point using a biphasic rectangular wave with a frequency of 2Hz and a pulse width of 200 ms. The stimulation will be achieved using the highest intensity tolerated by the patient without pain during 40 minuts. Once a day during 5 consecutive days.

Device: AcuTENS

Sham AcuTENS

SHAM COMPARATOR

Stimulation using a modified portable TENS electrostimulation device at Dingchuan point with no electrical output, even though the screen will light up and display the same data as in the unmodified device during 40 minuts. Patients in this group will be informed that, due to the frequency of stimulation, it is unlikely that they will feel the electric stimulation. Once a day during 5 consecutive days.

Device: Sham AcuTENS

Interventions

AcuTENSDEVICE

Stimulation of acupuncture point Dingchuan using transcutaneous electrical nerve stimulation (TENS) instead of needles

Also known as: TENS, Acupoint transcutaneous electrical nerve stimulation
AcuTENS

Portable TENS electrostimulation device with no electrical output

Sham AcuTENS

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 45 and 70 years, with a diagnose of COPD according to the GOLD guidelines.
  • Patients with one episode of hospitalization for COPD exacerbation in the past year, but not more than three episodes.
  • Smoking habit history of more than 10 packages-year.
  • Patients able to correctly understand and answer the modified Borg scale.
  • Patiens with an initial degree of dyspnoea with a score of at least 5 in the modified Borg scale.
  • Patients recruited for the study during the first 48 hours of their hospitalization.
  • Patients who accept to participate in the study and sign the informed consent.

You may not qualify if:

  • Patients with any contraindication for transcutaneous electrical stimulation (patiens with pacemakers, skin injury in the application area ...).
  • Patiens with any cardiovascular, neurological or psychiatric disease that may affect the perception of dyspnea.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Hospital Sant Joan de Déu de Manresa

Manresa, Barcelona, Spain

RECRUITING

Parc Sanitari de Sant Joan de Déu

Sant Boi de Llobregat, Barcelona, 08830, Spain

RECRUITING

Hospital del Mar

Barcelona, Spain

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Central Study Contacts

Carlres Fernández, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2016

First Posted

December 21, 2016

Study Start

April 1, 2018

Primary Completion

June 1, 2019

Study Completion

September 1, 2019

Last Updated

October 2, 2018

Record last verified: 2018-09

Locations